Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development
Drug Metabolism and Disposition · 2026
DOI: 10.1016/j.dmd.2025.100230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026. Verfasst von Ann-Kathrin Lenich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany. Hauptthemen laut MEDLINE: Spheroids, Cellular, Hepatocytes, Cytochrome P-450 Enzyme System, Drug Development. Die Arbeit nennt 77 Literaturangaben.
Abstract (Originalsprache)
3-dimensional (3D) primary hepatic spheroid cultures better mimic in vivo liver architecture and maintain a more stable cellular phenotype than the current gold standard of sandwich-cultured primary human hepatocytes. Therefore, they are a promising in vitro model for CYP enzyme induction and metabolism. This study aimed to evaluate long-term stability and suitability of primary human hepatic spheroids for regulatory-relevant in vitro applications, focusing on CYP enzyme metabolism and induction. Assay-ready spheroids were purchased from InSphero AG in monocultured, cocultured, single-, and multidonor formats. These were compared with 2-dimensional (2D) sandwich-cultured hepatocytes of the same donor. Basal activity of CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2B6, CYP2D6, CYP3A4, CYP2J2, UDP-glucuronosyltransferases, UGT1A1, and sulfotransferases was successfully measured in spheroids. Further, CYP1A1, CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2B6, and CYP3A4 were inducible by prototypical inducers at mRNA levels. The 6-fold induction threshold recommended by regulatory guidelines was exceeded in 4 of 5 donors. CYP1A2 (9- to 16-fold), CYP2B6 (6- to 15-fold), and CYP3A4 (7- to 35-fold) were robustly induced, qualifying the spheroid model for in vitro induction studies, despite lower induction levels compared with 2D cultures. No significant differences were observed between monocultured and cocultured spheroids. Spheroids maintained stable morphology and CYP enzyme activity for up to 4 weeks. Overall, primary human hepatic spheroids demonstrated suitability for CYP induction studies and for assessing compound metabolism in short- and long-term in vitro applications. A comprehensive assessment of how culture dimensionality and cellular composition affect CYP enzyme metabolism and induction is provided, supporting that spheroid cultures can be suitable for in vitro drug metabolism and pharmacokinetics applications. SIGNIFICANCE STATEMENT: This study explores the impact of culture dimensionality and cellular composition on CYP enzyme metabolism and induction. Primary human hepatocytes were characterized as monocultured, cocultured, single-, and multidonor 3-dimensional (3D) spheroids and compared with 2-dimensional primary human hepatocyte culture. The study provides a first thorough characterization of InSphero 3D InSight Human Liver Microtissues for suitability in in vitro drug metabolism and pharmacokinetics studies. By addressing interdonor variability and long-term functionality, the findings support the enhanced relevance and applicability of 3D liver models in drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.
- Department of Global Experimental Medicine Biomarker Platforms, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.
- Department of Global Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany. Electronic address: stephanie.ruez@boehringer-ingelheim.com.
Zitieren
APA
Lenich, A. K., Alsdorf, S., & Ruez, S. (2026). Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100230
Vancouver
Lenich AK, Alsdorf S, Ruez S. Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development. Drug Metabolism and Disposition. 2026. doi:10.1016/j.dmd.2025.100230
BibTeX
@article{Lenich2026,
author = {Lenich, Ann-Kathrin and Alsdorf, Sanja and Ruez, Stephanie},
title = {Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development},
journal = {Drug Metabolism and Disposition},
year = {2026},
doi = {10.1016/j.dmd.2025.100230}
}
EUVIMED